- Home
- RGC vs FIVE Comparison
RGC vs FIVE Comparison
Compare RGC & FIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$26.72
HOLD
Current Price
$205.46
Company Overview
Basic Information| Metric | RGC | FIVE |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 10.9B |
| IPO Year | 2021 | 2012 |
Fundamental Metrics
Financial Performance| Metric | RGC | FIVE |
|---|---|---|
| Price | $26.72 | $205.46 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 19 |
| Target Price | N/A | ★ $188.21 |
| AVG Volume (30 Days) | 416.1K | ★ 998.5K |
| Earning Date | 10-31-2025 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.58 |
| EPS | N/A | ★ 5.56 |
| Revenue | N/A | ★ $4,426,552,000.00 |
| Revenue This Year | N/A | $24.36 |
| Revenue Next Year | N/A | $10.00 |
| P/E Ratio | ★ N/A | $37.16 |
| Revenue Growth | N/A | ★ 15.78 |
| 52 Week Low | $0.09 | $52.38 |
| 52 Week High | $83.60 | $209.98 |
Technical Indicators
Market Signals| Indicator | RGC | FIVE |
|---|---|---|
| Relative Strength Index (RSI) | 48.29 | 62.24 |
| Support Level | $24.62 | $190.33 |
| Resistance Level | $28.99 | $209.98 |
| Average True Range (ATR) | 3.98 | 6.26 |
| MACD | -0.65 | 1.06 |
| Stochastic Oscillator | 17.31 | 80.85 |
Price Performance
Historical Comparison RGC
FIVE
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About FIVE Five Below Inc.
Five Below Inc is a specialty value retailer offering merchandise targeted at the tween and teen demographic. The Company's edited assortment of products includes select brands and licensed merchandise. It derives revenue from sales of the Company's merchandise to customers.